6.3 C
Innichen
October 2, 2022
Science and Medical

Palatin’s stock rockets after FDA OK to market sexual desire disorder treatment – MarketWatch

Palatin's stock rockets after FDA OK to market sexual desire disorder treatment - MarketWatch thumbnail

Shares of Palatin Technologies Inc.
PTN, -5.97%
rocketed 27% in very active premarket trading Monday, after a positive Food and Drug Administration decision on AMAG Pharmaceuticals Inc.’s
AMAG, -2.45%
treatment for hypoactive sexual desire disorder (HSD…
Read More

Related posts

Surgery for weight loss found to decrease risk of heart attack and stroke, study reports – CBS News

Administrator

Did Lawmakers Demand the Pentagon Disclose If It Developed Weaponized Ticks? – Snopes.com

Administrator

Cuba ‘sonic attacks’ changed people’s brains, study suggests – CNN

Administrator

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Policy